ZBH Zimmer Biomet
Updated
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Zimmer Biomet (ZBH) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $18.9 billion. Shares last traded at $98.88, 7.5% below their 52-week high. Over the past year the stock is down 5.9%. ZBH trades at a price-to-earnings ratio of 23.38, below the Orthopedic, Prosthetic & Surgical Appliances & Supplies median of 27.46. Net profit margin is 9.5%, above the peer median of 5.3%. Revenue grew 7.2% year over year. The shares yield 1.0% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
ZBH Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $190M | $0.96 | 27% |
| 2024-12-31 | $196M | $0.96 | 22% |
| 2023-12-31 | $201M | $0.96 | 20% |
| 2022-12-31 | $201M | $0.96 | 87% |
| 2021-12-31 | $200M | $0.95 | 50% |
| 2020-12-31 | $199M | $0.96 | — |
| 2019-12-31 | $197M | $0.95 | 17% |
| 2018-12-31 | $195M | $0.96 | — |
| 2017-12-31 | $194M | $0.95 | 11% |
| 2016-12-31 | $188M | $0.93 | 62% |
| 2015-12-31 | $157M | $0.83 | 107% |
| 2014-12-31 | $146M | $0.85 | 20% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $2.25 | 2026-08-05 |
| Q1 2026 | $1.22 | 2026-05-01 |
| FY 2025 | $3.55 | 2026-02-20 |
| Q3 2025 | $2.84 | 2025-11-05 |
| Q2 2026 | $1.68 | 2026-08-05 |
| Q1 2026 | $0.91 | 2026-05-01 |
Orthopedic, Prosthetic & Surgical Appliances & Supplies peers
ZBH vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Updated
| ISRG | Intuitive Surgical | $130.7B | 41.64 | 11.84 | 28.4% | -0.51% |
| EW | Edwards Lifesciences | $51.7B | 51.49 | 7.95 | 15.4% | -1.16% |
| STE | Steris | $22.1B | 27.46 | 3.66 | 13.3% | -1.52% |
| ZBH | Zimmer Biomet | $18.9B | 23.38 | 2.22 | 9.5% | -0.60% |
| ALGN | Align Technology | $11.4B | 27.46 | 2.74 | 10.0% | +0.45% |
| MSA | Msa Safety Inc | $7.2B | 23.08 | 3.72 | 16.1% | -0.34% |
| ESTA | Establishment Labs Holdings Inc. | $2.2B | -55.44 | 8.77 | -15.8% | -3.60% |
| CDRE | Cadre Holdings, Inc. | $1.3B | 35.47 | 1.87 | 5.3% | +4.26% |
| ENOV | Enovis Corp | $1.1B | -1.01 | 0.49 | -48.0% | -4.03% |
| AVR | Anteris Technologies Global Corp. | $851M | -8.22 | 379.49 | — | +1.51% |
| SMTI | Sanara MedTech Inc. | $319M | -9.95 | 2.90 | -29.2% | -0.33% |
| CNXU | Conexeu Sciences Inc. | $149M | — | — | — | -5.78% |
| INGN | Inogen Inc | $144M | -5.87 | 0.48 | -8.1% | +0.93% |
| LAKE | LAKELAND INDUSTRIES INC | $121M | -4.51 | 0.63 | -14.0% | +3.01% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.